Model
Edge
Regeneron Pharmaceuticals, Inc.
REGN
Filing Type
144
Filing Date
7/1/2026
Updated
7/2/26, 3:46 PM
Copy Ref
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities